Ganciclovir and high-dose valacyclovir reduce cytomegalovirus reactivation in patients receiving allogeneic stem cell transplantation with Campath-1H–based conditioning regimens
Open Access
- 1 February 2005
- journal article
- abstracts
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 11 (2) , 94
- https://doi.org/10.1016/j.bbmt.2004.12.277
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: